NeoGenomics, Inc. (NEO)
9.14
+0.04
(+0.44%)
USD |
NASDAQ |
Mar 05, 16:00
9.08
-0.06
(-0.66%)
After-Hours: 06:25
NeoGenomics Cash from Investing (TTM) : -12.34M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| AtriCure, Inc. | -14.55M |
| ADMA Biologics, Inc. | -21.89M |
| Krystal Biotech, Inc. | -58.42M |
| Alignment Healthcare, Inc. | -14.97M |
| Monte Rosa Therapeutics, Inc. | -67.66M |